Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,959 | -3,138 | -2,251 | -1,035 | -2,988 |
| Depreciation Amortization | 168 | 112 | 59 | 31 | 46 |
| Accounts receivable | 9 | 25 | 7 | 32 | 81 |
| Other Working Capital | 642 | 577 | 561 | -5 | -184 |
| Other Operating Activity | 210 | 337 | 225 | 132 | -109 |
| Operating Cash Flow | $-2,930 | $-2,089 | $-1,398 | $-845 | $-3,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -4 | -4 | -18 |
| Sale Of Investment | 1,488 | N/A | N/A | N/A | -749 |
| Purchase Sale Intangibles | -744 | -702 | N/A | N/A | N/A |
| Other Investing Activity | -744 | -702 | 0 | 0 | 0 |
| Investing Cash Flow | $740 | $-706 | $-4 | $-4 | $-768 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 721 | 709 | N/A | N/A | N/A |
| Common Stock Issued | 2,651 | 15 | N/A | N/A | 3,573 |
| Other Financing Activity | 420 | 828 | 406 | 196 | 392 |
| Financing Cash Flow | $3,792 | $1,552 | $406 | $196 | $3,965 |
| Beginning Cash Position | 1,337 | 1,314 | 1,307 | 1,366 | 1,309 |
| End Cash Position | 2,938 | 72 | 311 | 712 | 1,352 |
| Net Cash Flow | $1,601 | $-1,243 | $-996 | $-653 | $44 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,930 | -2,089 | -1,398 | -845 | -3,154 |
| Capital Expenditure | -4 | -4 | -4 | -4 | -18 |
| Free Cash Flow | -2,935 | -2,093 | -1,402 | -849 | -3,173 |